Ethical Performance
inside intelligence for responsible business

Merck launches 2008 global corporate responsibility report


View Full Report

Today Merck & Co., Inc. (Whitehouse Station, NJ, USA)* launched its 2008 global corporate responsibility (CR) report in which it emphasizes that the fundamentals of good corporate governance and accountability, ethical business practices, and transparency have never been more important. To access Merck's report, visit

"In tough economic times, it is tempting for a company to retreat back to more parochial business concerns," said Richard T. Clark, Chairman, President and CEO of Merck & Co., Inc. "However, we believe that good corporate citizenship and good governance have never been more important."

The report covers the pharmaceuticals company's corporate responsibility activities, progress and performance during 2008 in five priority areas that the Company has identified as critical to its business:

  Researching new medicines and vaccines to address unmet needs
  Improving access to medicines, vaccines and health care
  Ensuring confidence in the safety and quality of its products
  Conducting business ethically and transparently
  Managing the company's environmental footprint

It also includes additional information related to the Company's activities in the first half of 2009.

Merck uses several external guidelines and measurement frameworks to inform the scope of its reporting, including the Global Reporting Initiative (GRI 3) guidelines, the Millennium Development Goals, the Access to Medicines Index and, for the first time, the UN Global Compact, which the Company signed on to in January 2009.

The theme of this year's report -- "Advancing the dialogue toward a healthier future" -- emphasizes Merck's ongoing commitment to engagement with stakeholders to ensure that its approach to corporate responsibility reflects both public expectations and its long-standing Company values. The theme is illustrated in the report through a series of dialogues with stakeholders and Merck senior management on the role of the pharmaceutical industry in society today.

To request a print copy of the report, go to

In addition to the 64-page print report, additional information, case studies and metrics are available at The Company encourages stakeholder feedback on the report at Merck plans to publish its next report in 2010.

*Merck & Co., Inc. operates as Merck Sharp & Dohme (MSD) in most countries outside the United States.

View Full Report
3BL Media News
Sign up for Free e-news
Report Alerts
Job Vacancies
Events Updates
Best Practice Newsletter